Ninety three per cent of gail bladders were shown to be functioning and nine (9.8%) contained stones, although five of these are believed to have developed from residual fragments. Percutaneous cholecystolithotomy is a safe, non-operative treatment for symptomatic gall stones and enabled the patient to fully recover within two to three weeks; it has a definite role in the management of the elderly and high risk patient but its use for the treatment of other groups is likely to remain controversial.
Abstract
Between January 1988 and December 1990, 283 patients with symptomatic gall stones were referred for non-operative treatment. After ultrasound scanning including a functional assessment, 220 (78%) patients were found to be suitable for percutaneous cholecystolithotomy. Of these, 113 underwent the procedure including 10 in whom extracorporeal shockwave lithotripsy or methyl tert-butyl ether therapy had failed. Forty four patients underwent extracorporeal shockwave lithotripsy, methyl tertbutyl ether therapy or rotary lithotripsy, 46 chose laparoscopic cholecystectomy or minicholecystectomy and 27 declined treatment. Percutaneous cholecystolithotomy was successfully performed in 100 patients. Thirty four patients were a high operative risk and 14 presented with an acute complication of gall stone disease. Complications developed in 15 patients, all of whom were managed conservatively and most occurred during development of the technique. Outcome has been assessed clinically and by ultrasound scauning in 92 patients with a median follow up period of 14 months (six to 37 months). Seventy nine per cent were completely cured oftheir symptoms.
Ninety three per cent of gail bladders were shown to be functioning and nine (9.8%) contained stones, although five of these are believed to have developed from residual fragments. Percutaneous cholecystolithotomy is a safe, non-operative treatment for symptomatic gall stones and enabled the patient to fully recover within two to three weeks; it has a definite role in the management of the elderly and high risk patient but its use for the treatment of other groups is likely to remain contro- Accepted for publication 15 (Table II) . Decompression of 13 of the 14 acute gall bladders for seven to 10 days resulted in resolution of acute cholecystitis (six), mucocoeles (two), perforated empyemas associated with liver abscesses (two), and jaundice alone, with empyema or with pancreatitis (three) before stone extraction was undertaken. The procedure failed in one patient because of failed puncture and dilatation and in another, whose (Table VI) . The number of patients with recurrent stones compared with the total number scanned was three of 72 at three to five months, two of 82 at six to 11 months, two of 56 at 12-17 months, one of 21 at 18-23 months, one of three at 24-35 months, and 0 of two at 36-47 months. Stone recurrences in five patients are believed to be the result of residual stones as they reformed by the six month follow up examination and each of the post procedure contrast studies had shown a filling defect in the neck of the gall bladder or cystic duct. They were classified as successes of treatment as subsequent radiological examination had been normal. Seven of the nine patients with stone recurrence are asymptomatic (symptom score 0) and the other two have a symptom score of 1. When gall bladder emptying was assessed 86 (93%) showed a reduction in volume of >30% after the fatty meal stimulus. Gall bladder emptying was restored to eight of 10 patients managed with an acutely inflamed gall bladder and to 11 of 13 patients with nonfunction because of a stone impacted in Hartmann's pouch (Table II) In this study, 107 patients (95%) underwent successful clearance of gall bladder stones but seven of these had a residual cystic duct stone, reducing the overall success rate to 89%. Only two of the patients with residual cystic duct stones were advised to undergo cholecystectomy and the remainder are asymptomatic. In their separate experience, Kellett et al reported successful stone clearance in 56 of 60 fit patients (93%) with non-acute gall stone disease. 17 None of their patients had cystic duct stones. Unlike other non-operative treatments, a nonfunctioning gall bladder with a stone impacted in Hartmann's pouch is not a contraindication to treatment and stones were removed successfully in 15 of 16 patients with a return of cystic duct patency. Draining the gall bladder for seven to 10 days before stone extraction allowed the stone to disimpact in over half of the patients making stone extraction easier. Patients with acute complications of gall bladder stones, were similarly managed by drainage to allow the acute inflammation to resolve before stone extraction was attempted. The safety and efficacy of undertaking stone extraction in the acute gall bladder, when it is friable and difficult to examine thoroughly, is questionable. There has been no mortality associated with percutaneous cholecystolithotomy and most of the complications occurred during development and refinement of the technique. The transperitoneal approach to the gall bladder is usually avoided because of the risk of intraperitoneal bile leakage or bdwel perforation. The approach enables larger cannulae to be used for easier stone extraction, however, and avoids unnecessary trauma to the liver. Hruby et al assessed 100 computed tomography scans of gall bladders in gall stone patients and predicted that safe peritoneal puncture was not possible in 34% of patients.'8 Our experience with the transperitoneal approach does not confirm these findings. Intraperitoneal bile leakage only occurred early in the study when it was our policy to spigot the drainage catheter after 48 hours, rather than maintain free drainage until a tract to the skin had formed. There has been no injury to bowel in the 113 patients in whom the procedure was attempted, although others have reported this complication. 17 After cholecystectomy, 30-50% of patients develop post cholecystectomy symptoms and 34-50% of these complain of wound pain one to two years later.'920 Although the gall bladder is considered to be dispensible, its preservation may result in a reduction of post cholecystectomy symptoms. In this study, 79% of patients were cured of their symptoms. Seven per cent reported that their symptoms were unchanged which reflects the difficulty of being certain that symptoms are caused by gall stones. With the minimal scarring of a 1 cm incision, wound pain has not been a problem. Overall, there seems to be a lower incidence of symptoms after percutaneous cholecystolithotomy than cholecystectomy. The main argument against any method which preserves the gall bladder is stone recurrence but to assume that all patients will develop stone recurrence is incorrect. Stone recurrence after bile acid therapy occurs in approximately 50% of patients within five years of treatment and then reaches a plateau of 61% by the 11th year.2' 22 The early recurrences may be the result of incomplete clearance of the gall bladder which is not detected by radiological examination. Stone recurrence after extracorporeal shockwave lithotripsy is expected to be similar and has been reported as 9% in the first year.23 It is too early to establish whether recurrent stone formation after percutaneous cholecystolithotomy differs from other non-operative treatments. Recurrent stones in five of the nine patients followed up for a median of 14 months are believed to have developed from residual fragments. Even with endoscopic clearance, which should be more thorough, it is often difficult to remove radiologically undetectable, tiny fragments adherent to or embedded in the mucosa and therefore, latterly, patients have been given adjuvant bile acid therapy for an arbitrary three month period. The only patient given bile acid therapy who developed stone recurrence, stopped treatment after only two weeks because of side effects. Stone recurrence in these patients seems to be less than those not given adjuvant therapy but the length of follow up is shorter. In the future, it may be feasible to ablate the gall bladder by thermal or chemical injury or to prevent gall stone formation by altering bile metabolism. 24 After percutaneous cholecystolithotomy, the majority (93%) of gall bladders emptied satisfactorily including patients who had nonfunctioning gall bladders before treatment because of an acute complication or an impacted stone. This finding adds support to the argument for the continued use of methods which preserve the gall bladder.
Percutaneous cholecystolithotomy is a highly successful, minimally invasive technique with a short hospital stay and rapid convalescence. It has proved particularly useful for the management of high risk patients such as the medically unfit, frail and elderly in whom cholecystectomy is associated with mortality rates of 10%, or higher when carried out for acute complications. 25 Its use in other groups of patients is likely to remain controversial, particularly with the introduction of less invasive methods of cholecystectomy, such as minicholecystectomy and laparoscopic cholecystectomy. 
